W328655

Tripropionin

≥97.1%, FCC, FG

• Sinónimos: Glyceryl tripropionate
• Fórmula lineal: (C₂H₅CO₂CH₂)₂CH(O₂CC₂H₅)
• Número de CAS: 139-45-7
• Peso molecular: 260.28
• FEMA Number: 3286
• MDL number: MFCD00027005
• UNSPSC Code: 12164502
• Flavis number: 9.263

Propiedades

• biological source: synthetic
• Quality Level: 400
• grade: FG; Halal
• agency: meets purity specifications of JECFA
• reg. compliance: EU Regulation 1334/2008 & 178/2002; FCC; FDA 21 CFR 117
• vapor density: 8.95 (vs air)
• assay: ≥97.1%
• autoignition temp.: 790 °F
• expl. lim.: 0.8 %, 186 °F
• refractive index: n20/D 1.434 (lit.)
• bp: 175-176 °C/20 mmHg (lit.)
• density: 1.08 g/mL at 25 °C (lit.)
• documentation: see Safety & Documentation for available documents
• food allergen: no known allergens
• organoleptic: oily; chemical
• SMILES string: CCC(=O)OCC(COC(=O)CC)OC(=O)CC
• InChI: 1S/C12H20O6/c1-4-10(13)16-7-9(18-12(15)6-3)8-17-11(14)5-2/h9H,4-8H2,1-3H3
• InChI key: YZWRNSARCRTXDS-UHFFFAOYSA-N

Descripción

Application

• The gut microbiome modulates the impact of Anaerobutyricum soehngenii supplementation on glucose homeostasis in mice.: This study investigates how the gut microbiome affects glucose homeostasis in mice supplemented with Anaerobutyricum soehngenii. Findings suggest a significant role of microbial interactions in metabolic regulation (Hutchison et al., 2024).


• Development and cytotoxicity evaluation of multiple nanoemulsions for oral co-delivery of 5-fluorouracil and short chain triglycerides for colorectal cancer.: This paper explores the development of nanoemulsions containing 5-fluorouracil and short-chain triglycerides, including tripropionin, for targeted cancer therapy, highlighting their potential in improving drug delivery and efficacy (Fukumori et al., 2023).


• Gastrointestinal digestion of Pickering emulsions stabilised by hydrophobically modified cellulose nanocrystals: Release of short-chain fatty acids.: This study examines the digestion of Pickering emulsions stabilized by modified cellulose nanocrystals, focusing on the release of short-chain fatty acids, including those from tripropionin, during gastrointestinal digestion (Le et al., 2020).


• Evaluation of lipid-stabilised tripropionin nanodroplets as a delivery route for combretastatin A4.: This research evaluates the use of lipid-stabilized tripropionin nanodroplets for the delivery of the anticancer drug combretastatin A4, demonstrating enhanced stability and targeted delivery potential (Mico et al., 2017).

Información de seguridad

• Storage Class: 10 - Combustible liquids
• wgk_germany: WGK 2
• flash_point_f: No data available
• flash_point_c: No data available